Terazosin Impurity 9(Terazosin EP Impurity I);Terazosin EP Impurity I (Mixture of Diastereomers);[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-[(5S)-5-methyloxolan-2-yl]methanone;Methanone, [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl][(5S)-tetrahydro-5-methyl-2-furanyl]-;Terazosin Impurity I;[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl][(5S)-tetrahydro-5-methyl-2-furanyl]methanon;(4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)((5S)-5-methyltetrahydrofuran-2-yl)methanone (Terazosin Impurity);[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl][(5S)-tetrahydro-5-methyl-2-furanyl]methanone
For laboratory research purposes. Not for drug or household use.
信号词
Warning
InChIKey
HKXGJHSYGLAWLN-SFVWDYPZSA-N
危险类别(旧)
H302,H315,H319,H335
存储要求
No data available,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage.
安全信息
危险品分类
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A),Specific target organ toxicity, single exposure; Respiratory system (Category 3)